The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
PTEN: a new guardian of the genome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chung, J.-H., Ginn-Pease, M. E., & Eng, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0124 · Cited by 164
Retractedp53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 2×
“Tumor suppressor network: p53, PTEN and beyond p53 is the most frequently mutated gene in human cancers (Vogelstein et al., 2000; Levine et al., 2004).”
BackgroundLane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“…factor that regulates target genes (Levine, 1997). p53 controls cellcycle progression, apoptosis and genomic stability (Yonish-Rouach et al., 1991; Kastan et al., 1992; Livingstone et al., 1992; Yin et al., 1992; Lowe et al., Oncogene 1993; Tlsty et al., 1994). p53 is the first to be proposed as…”
BackgroundA human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948 · cited 1×
“Rb plays an important role in controlling cell cycle progression (Friend et al., 1986; Weinberg, 1992).”
Backgroundp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
Cully, M., You, H., Levine, A. J., & Mak, T. W. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1819 · Cited by 1,233
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
Tamura, M., Gu, J., Matsumoto, K., Aota, S.-I., Parsons, R., & Yamada, K. M. (1998) · Science · doi:10.1126/science.280.5369.1614 · Cited by 1,215
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,168
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Self-citationCrystal Structure of the PTEN Tumor Suppressor
Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,014
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Self-citationMutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., & Parsons, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 946
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
Li, D., & Sun, H. (1997) · PubMed · Cited by 866
Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., Barrantes, I. D. B., Ho, A., Wakeham, A., ltie, A., Khoo, W., et al. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00488-5 · Cited by 818
Sun, H., Lesche, R., Li, D.-M., Liliental, J., Zhang, H., Gao, J., Gavrilova, N., Mueller, B., Liu, X., & Wu, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6199 · Cited by 796
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9052 · Cited by 775
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN
Wang, X., Trotman, L. C., Koppie, T., Alimonti, A., Chen, Z., Gao, Z., Wang, J., Erdjument-Bromage, H., Tempst, P., Cordon-Cardo, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.039 · Cited by 720
Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 714
PTEN: Life as a Tumor Suppressor
Simpson, L., & Parsons, R. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5130 · Cited by 679
Ramaswamy, S., Nakamura, N., Vazquez, F., Batt, D. B., Perera, S., Roberts, T. M., & Sellers, W. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2110 · Cited by 575
Freeman, D. J., Li, A. G., Wei, G., Li, H.-H., Kertesz, N., Lesche, R., Whale, A. D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R. D., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00021-7 · Cited by 515
(1997) · PubMed · Cited by 512
Backman, S. A., Stambolic, V., Suzuki, A., Haight, J., Elia, A., Pretorius, J., Tsao, M.-S., Shannon, P., Bolon, B., Ivy, G. O., et al. (2001) · Nature Genetics · doi:10.1038/ng782 · Cited by 508
Li, D.-M., & Sun, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15406 · Cited by 489
Protean PTEN: Form and Function
Waite, K. A., & Eng, C. (2002) · The American Journal of Human Genetics · doi:10.1086/340026 · Cited by 457
PTEN function: how normal cells control it and tumour cells lose it
LESLIE, N. R., & DOWNES, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20040825 · Cited by 451
Growth suppression by p16ink4 requires functional retinoblastoma protein
Medema, R. H., Herrera, R. E., Lam, F., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6289 · Cited by 433
Kurose, K., Gilley, K., Matsumoto, S., Watson, P. H., Zhou, X.-P., & Eng, C. (2002) · Nature Genetics · doi:10.1038/ng1013 · Cited by 418
The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network
Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 410
Identification of a tumour suppressor network opposing nuclear Akt function
Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature04809 · Cited by 394
High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.
Stambolic, V., Tsao, M., MacPherson, D. P., Suzuki, A., Chapman, W. B., & Mak, T. W. (2000) · PubMed · Cited by 356
Saal, L. H., Gruvberger-Saal, S. K., Persson, C., Lövgren, K., Jumppanen, M., Staaf, J., Jönsson, G., Pires, M. M., Maurer, M., Holm, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.39 · Cited by 355
Børresen-Dale, A.-L. (2003) · Human Mutation · doi:10.1002/humu.10174 · Cited by 354
PTEN: from pathology to biology
Sulis, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00175-2 · Cited by 344
Membrane-binding and activation mechanism of PTEN
Das, S., Dixon, J. E., & Cho, W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932835100 · Cited by 335
Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN
Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S., & Hall, A. (2004) · Science · doi:10.1126/science.1092089 · Cited by 335
Gu, J., Tamura, M., & Yamada, K. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.5.1375 · Cited by 334
Lack of PTEN sequesters CHK1 and initiates genetic instability
Puc, J., Keniry, M., Li, H. S., Pandita, T. K., Choudhury, A. D., Memeo, L., Mansukhani, M., Murty, V. V. V. S., Gaciong, Z., Meek, S. E. M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.009 · Cited by 328
Gimm, O., Perren, A., Weng, L.-P., Marsh, D. J., Yeh, J. J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J. A., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65040-7 · Cited by 327
The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region
Georgescu, M.-M., Kirsch, K. H., Akagi, T., Shishido, T., & Hanafusa, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10182 · Cited by 317
Protein modules as organizers of membrane structure
Fanning, A. S., & Anderson, J. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80062-3 · Cited by 310
Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M. P., Tonks, N. K., & Parsons, R. E. (1998) · PubMed · Cited by 306
Liliental, J., Moon, S. Y., Lesche, R., Mamillapalli, R., Li, D., Zheng, Y., Sun, H., & Wu, H. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00417-6 · Cited by 293
TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Langerød, A., Zhao, H., Borgan, Ø., Nesland, J. M., Bukholm, I. R., Ikdahl, T., Kåresen, R., Børresen-Dale, A.-L., & Jeffrey, S. S. (2007) · Breast Cancer Research · doi:10.1186/bcr1675 · Cited by 291
Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64624-x · Cited by 266
(1999) · PubMed · Cited by 258
Identification of the JNK Signaling Pathway as a Functional Target of the Tumor Suppressor PTEN
Vivanco, I., Palaskas, N., Tran, C., Finn, S. P., Getz, G., Kennedy, N. J., Jiao, J., Rose, J., Xie, W., Loda, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.021 · Cited by 245
Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production
Kimura, T., Suzuki, A., Fujita, Y., Yomogida, K., Lomeli, H., Asada, N., Ikeuchi, M., Nagy, A., Mak, T. W., & Nakano, T. (2003) · Development · doi:10.1242/dev.00392 · Cited by 245
Weng, L.-P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.3.237 · Cited by 234
A Role for Nuclear PTEN in Neuronal Differentiation
Lachyankar, M. B., Sultana, N., Schonhoff, C. M., Mitra, P., Poluha, W., Lambert, S., Quesenberry, P. J., Litofsky, N. S., Recht, L. D., Nabi, R., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01404.2000 · Cited by 230
Human cancer, PTEN and the PI-3 kinase pathway
Parsons, R. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.021 · Cited by 224
Emerling, B. M., Weinberg, F., Liu, J.-L., Mak, T. W., & Chandel, N. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706790105 · Cited by 217
Weng, L.-P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.605 · Cited by 199
Whiteman, D. C., Zhou, X., Cummings, M. C., Pavey, S., Hayward, N. K., & Eng, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10294 · Cited by 187
P53 is a tumor suppressor gene
Levine, A. J., Finlay, C. A., & Hinds, P. W. (2004) · Cell · doi:10.1016/s0092-8674(04)00036-4 · Cited by 185
PtdIns(3,4,5)P3-Dependent and -Independent Roles for PTEN in the Control of Cell Migration
Leslie, N. R., Yang, X., Downes, C. P., & Weijer, C. J. (2007) · Current Biology · doi:10.1016/j.cub.2006.12.026 · Cited by 184
Fujisawa, H., Reis, R. M., Nakamura, M., Colella, S., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780009 · Cited by 180
Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.
Georgescu, M. M., Kirsch, K. H., Kaloudis, P., Yang, H., Pavletich, N. P., & Hanafusa, H. (2000) · PubMed · Cited by 176
Baker, S. J. (2007) · Cell · doi:10.1016/j.cell.2006.12.023 · Cited by 171
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
Backman, S. A., Ghazarian, D., So, K., Sanchez, O., Wagner, K.-U., Hennighausen, L., Suzuki, A., Tsao, M.-S., Chapman, W. B., Stambolic, V., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308217100 · Cited by 159
Chang, C.-J., Mulholland, D. J., Valamehr, B., Mosessian, S., Sellers, W. R., & Wu, H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00310-08 · Cited by 155
Park, M., Kim, M., Park, I., Kang, H., Yoo, H., Park, S. H., Rhee, C. H., Hong, S., & Lee, S. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80906-6 · Cited by 154
Mayo, M. W., Madrid, L. V., Westerheide, S. D., Jones, D. R., Yuan, X., Baldwin, A. S., & Whang, Y. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108670200 · Cited by 123
The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.
Maier, D., Jones, G., Li, X., Schönthal, A. H., Gratzl, O., Meir, E. G. V., & Merlo, A. (1999) · PubMed · Cited by 119
PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
Paramio, J. M., Navarro, M., Segrelles, C., Gómez‐Casero, E., & Jorcano, J. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203151 · Cited by 117
Ginn‐Pease, M. E., & Eng, C. (2003) · PubMed · Cited by 116
PTEN enters the nucleus by diffusion
Liu, F., Wagner, S., Campbell, R. B., Nickerson, J. A., Schiffer, C. A., & Ross, A. H. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20525 · Cited by 114
Nuclear PTEN-Mediated Growth Suppression Is Independent of Akt Down-Regulation
Liu, J.-L., Sheng, X., Hortobagyi, Z. K., Mao, Z., Gallick, G. E., & Yung, W. K. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6211-6224.2005 · Cited by 109
PTEN Represses RNA Polymerase III-Dependent Transcription by Targeting the TFIIIB Complex
Woiwode, A., Johnson, S. A. S., Zhong, S., Zhang, C., Roeder, R. G., Teichmann, M., & Johnson, D. L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01912-07 · Cited by 104
PTEN Regulates Mdm2 Expression through the P1 Promoter
Chang, C.-J., Freeman, D. J., & Wu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401488200 · Cited by 104
Mahimainathan, L., & Choudhury, G. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314328200 · Cited by 103
PTEN Loss Inhibits CHK1 to Cause Double Stranded-DNA Breaks in Cells
Puc, J., & Parsons, R. E. (2005) · Cell Cycle · doi:10.4161/cc.4.7.1795 · Cited by 101
Functional evaluation of p53 and PTEN gene mutations in gliomas.
Kato, H., Kato, S., Kumabe, T., Sonoda, Y., Yoshimoto, T., Kato, S., Han, S., Suzuki, T., Shibata, H., Kanamaru, R., et al. (2000) · PubMed · Cited by 98
PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner
Tang, Y., & Eng, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1557 · Cited by 97
The Li–Fraumeni Syndrome: From Clinical Epidemiology to Molecular Genetics
Strong, L. C., Williams, W. R., & Tainsky, M. A. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116271 · Cited by 91
Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
Matsushima-Nishiu, M., Unoki, M., Ono, K., Tsunoda, T., Minaguchi, T., Kuramoto, H., Nishida, M., Satoh, T., Tanaka, T., & Nakamura, Y. (2001) · PubMed · Cited by 90
McGarrity, T. J., Baker, M. J., Ruggiero, F. M., Thiboutot, D. M., Hampel, H., Zhou, X.-P., & Eng, C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07496.x · Cited by 85
Minaguchi, T., Waite, K. A., & Eng, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2240 · Cited by 85
The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer
Bilbao, C., Rodríguez, G., Ramírez‐Moreno, R., Falcón, O., León, L., Chirino, R., Rivero, J. F., Falcón, O., Díaz-Chico, B. N., Díaz-Chico, J. C., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21862 · Cited by 84
PTEN and inherited hamartoma-cancer syndromes
Eng, C., & Peacocke, M. (1998) · Nature Genetics · doi:10.1038/897 · Cited by 83
Weng, L. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.15.1687 · Cited by 81
Hong, T.-M., Yang, P., Peck, K., Chen, J. J. W., Yang, S., Chen, Y.-C., & Wu, C. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.3.4002 · Cited by 73
Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle, D. E., Ashmun, R. A., Hannon, G. J., Rehberger, P. A., Trono, D., Richter, K. H., Walker, C., Beach, D., Sherr, C. J., & Serrano, M. (1995) · PubMed · Cited by 69
The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity
Nan, B., Snabboon, T., Unni, E., X-J, Y., Whang, Y. E., & Marcelli, M. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310169 · Cited by 69
Flores‐Delgado, G., Liu, C. W. Y., Sposto, R., & Berndt, N. (2007) · Journal of Proteome Research · doi:10.1021/pr060504h · Cited by 60
Moon, S., Kim, H.-M., & Kim, C. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.11.007 · Cited by 58
p18Ink4c and Pten Constrain a Positive Regulatory Loop between Cell Growth and Cell Cycle Control
Bai, F., Pei, X., Pandolfi, P. P., & Xiong, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00266-06 · Cited by 53
Regulation of c-Met-dependent gene expression by PTEN
Abounader, R., Reznik, T. E., Colantuoni, C., Martínez-Murillo, F., Rosen, E. M., & Laterra, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208146 · Cited by 53
Life, Death, and Ubiquitin: Taming the Mule
Shmueli, A., & Oren, M. (2005) · Cell · doi:10.1016/j.cell.2005.06.018 · Cited by 53
Shmueli, A., & Oren, M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00529-x · Cited by 51
Kang-Park, S., Lee, Y. I., & Lee, Y. I. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00535-0 · Cited by 48
Agrawal, S., Pilarski, R., & Eng, C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi246 · Cited by 47
Bischoff, F. Z., Strong, L. C., Yim, S. O., Pratt, D. R., Siciliano, M. J., Giovanella, B. C., & Tainsky, M. A. (1991) · PubMed · Cited by 36
PTEN down regulates AP-1 and targets c-fos in human glioma cells Via PI3-kinase/Akt pathway
Koul, D., Shen, R., Shishodia, S., Takada, Y., Bhat, K., Reddy, S. A. G., Aggarwal, B. B., & Yung, W. K. A. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9371-8 · Cited by 35
Research works printed but not linked: 10
- Gildea JJ, Herlevsen M, Harding MA, Gulding KM, Moskaluk CA, Frierson HF et al. (2004). PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 23: 6788–6797. · doi:10.1038/sj.onc.1207599
- Iida S, Nakamura Y, Fujii H, Kimura M, Moriwaki K . (1998). A heterozygous germline mutation of the PTEN/MMAC1 gene in a patient with Cowden disease. Int J Mol Med 1: 565–568.
- Iida S, Ono A, Sayama K, Hamaguchi T, Fujii H, Nakajima H et al. (2000). Accelerated decline of blood glucose after intravenous glucose injection in a patient with Cowden disease having a heterozygous germline mutation of the PTEN/MMAC1 gene. Anticancer Res 20: 1901–1904.
- Kanaseki T, Torigoe T, Hirohashi Y, Hirai I, Himi T, Sato N . (2002). Identification of germline mutation of PTEN gene and analysis of apoptosis resistance of the lymphocytes in a patient with Cowden disease. Pathobiology 70: 34–39. · doi:10.1159/000066001
- Kang-Park S, Lee YI, Lee YI . (2003). PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells. FEBS Lett 545: 203–208. · DOI
- Koul A, Willen R, Bendahl PO, Nilbert M, Borg A . (2002). Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Cancer 94: 2369–2379. · doi:10.1002/cncr.10498
- Okumura K, Zhao M, DePinho RA, Furnari FB, Cavenee WK . (2005). PTEN: a novel anti-oncogenic function independent of phosphatase activity. Cell Cycle 4: 540–542. · doi:10.4161/cc.4.4.1614
- Shin KH, Kim JM, Rho KS, Park KH, Oh JE, Min BM . (2002). Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas. Int J Oncol 21: 997–1001.
- Tlsty TD, White A, Livanos E, Sage M, Roelofs H, Briot A et al. (1994). Genomic integrity and the genetics of cancer. Cold Spring Harb Symp Quant Biol 59: 265–275. · doi:10.1101/sqb.1994.059.01.031
- Weinberg RA . (1992). The retinoblastoma gene and gene product. Cancer Surv 12: 43–57.
Cited by
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
A compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,296
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Patterson, K. I., Brummer, T., O'brien, P. M., & Daly, R. J. (2009) · Biochemical Journal · doi:10.1042/bj20082234 · Cited by 744
Metadata
- Authors
- Yin, Y., & Shen, W. H.
- Venue
- Oncogene
- Published
- 2008-09-15
- Volume
- 27
- Issue
- 41
- Pages
- 5443-5453
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2091338477
- Cited by
- 388
- References
- 113
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.